Grantham, Mayo, Van Otterloo & Co (GMO)’s AMERN STRATEGIC INCM PORTF II BSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-479,500
Closed -$4.21M 524
2014
Q2
$4.21M Hold
479,500
0.01% 292
2014
Q1
$3.98M Hold
479,500
0.01% 327
2013
Q4
$3.7M Buy
479,500
+441,194
+1,152% +$3.53M 0.01% 352
2013
Q3
$311K Buy
+38,306
New +$307K ﹤0.01% 610

Grantham, Mayo, Van Otterloo & Co (GMO)'s BSP Position: Q3 2014 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of AMERN STRATEGIC INCM PORTF II (BSP) in Q3 2014, closing a stake of 479,500 shares — an estimated $4.21M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BSP in Q3 2013 and held it in 4 quarters. The position peaked at $4.21M in Q2 2014. 0 funds tracked by Wall St. Rank hold BSP as of Q3 2014.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining AMERN STRATEGIC INCM PORTF II position as of Q3 2014 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 479,500 AMERN STRATEGIC INCM PORTF II shares in Q3 2014, an estimated $4.21M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AMERN STRATEGIC INCM PORTF II in Q3 2013 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s AMERN STRATEGIC INCM PORTF II position peaked at $4.21M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held AMERN STRATEGIC INCM PORTF II as of Q3 2014.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2014, filed 13 Nov 2014.